Literature DB >> 1720782

Rapid detection of proliferating potential in human brain tumors by nucleolar organizer region staining on squash preparations.

A Hara1, N Sakai, H Yamada, N Yoshimi, T Tanaka, H Mori.   

Abstract

Rapid detection of the proliferating potential of 37 human brain tumors was attempted using squash preparations stained by a silver colloid technique for argyrophilic protein associated with nucleolar organizer regions (AgNORs). Less than 1 h was required for staining. The mean number of AgNORs in cell nuclei of malignant or recurrent brain tumors (16 cases) including meningeal sarcoma, recurrent meningioma, recurrent craniopharyngioma, anaplastic astrocytoma, glioblastoma multiforme and metastatic brain tumor was 3.18, and the number for benign brain tumors (21 cases) including meningioma, neurinoma, pituitary adenoma, benign astrocytoma, ependymoma, and adenoma of lachrymal gland was 1.85. The former value was significantly greater than the latter value (P less than 0.001). These results indicate that quantitative analysis of AgNORs in brain neoplastic cells, using squash preparations, is useful to differentiate malignant from benign tumors within 1 h. Thus, this method provides rapid and useful information about the proliferative potential of human brain tumors even during operation.

Entities:  

Mesh:

Year:  1991        PMID: 1720782     DOI: 10.1007/bf01613280

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  19 in total

1.  Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.

Authors:  A Hara; H Hirayama; N Sakai; H Yamada; T Tanaka; H Mori
Journal:  Surg Neurol       Date:  1990-05

2.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

3.  Nucleolar organizer regions in Spitz nevi and malignant melanomas.

Authors:  A J Howat; D D Giri; D W Cotton; D N Slater
Journal:  Cancer       Date:  1989-02-01       Impact factor: 6.860

4.  The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.

Authors:  P C Burger; T Shibata; P Kleihues
Journal:  Am J Surg Pathol       Date:  1986-09       Impact factor: 6.394

5.  Value of AgNOR method in predicting recurrence of meningioma.

Authors:  A P Boon; H Sharif
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

6.  Argyrophilic nuclear and nucleolar proteins of Xenopus laevis oocytes identified by gel electrophoresis.

Authors:  M A Williams; J A Kleinschmidt; G Krohne; W W Franke
Journal:  Exp Cell Res       Date:  1982-02       Impact factor: 3.905

7.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

8.  The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours.

Authors:  C B Ostertag; B Volk; T Shibata; P Burger; P Kleihues
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

9.  Silver colloid staining technique for analysis of glioma malignancy.

Authors:  K Kajiwara; T Nishizaki; T Orita; H Nakayama; H Aoki; H Ito
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

10.  The use of the monoclonal antibody Ki-67 in determination of the growth fraction in pediatric brain tumors.

Authors:  T Shibata; P C Burger
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

View more
  2 in total

Review 1.  Comparative aspects of neoplastic invasion of the brain.

Authors:  H E Kaiser
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 2.  Techniques to assess the proliferative potential of brain tumors.

Authors:  Alfredo Quiñones-Hinojosa; Nader Sanai; Justin S Smith; Michael W McDermott
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.